Royal Bank Of Canada Vaccinex, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.34 - $0.48 $181 - $256	534 Added 12.95%	4,657 $1,000
Q1 2023 May 15, 2023	SELL	$0.39 - $0.65 $401 - $669	-1,030 Reduced 19.99%	4,123 $1,000
Q4 2022 Feb 14, 2023	SELL	$0.44 - $131.17 $117 - $34,891	-266 Reduced 4.91%	5,153 $3,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $109.22 $127 - $29,052	266 Added 5.16%	5,419 $3,000
Q1 2022 May 16, 2022	BUY	$0.92 - $1.94 $4,740 - $9,996	5,153 New	5,153 $7,000
Q4 2021 Feb 14, 2022	SELL	$1.04 - $2.12 $1,040 - $2,120	-1,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.11 - $2.81 $2,097 - $2,793	994 Added 16566.67%	1,000 $2,000
Q2 2021 Aug 16, 2021	BUY	$2.01 - $3.0 $12 - $18	6 New	6 $0

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $49.1M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.